首页> 外文期刊>Journal of medicinal food >Hexadecanoic acid from Buzhong Yiqi decoction induced proliferation of bone marrow mesenchymal stem cells.
【24h】

Hexadecanoic acid from Buzhong Yiqi decoction induced proliferation of bone marrow mesenchymal stem cells.

机译:补中益气汤加十六烷酸诱导骨髓间充质干细胞增殖。

获取原文
获取原文并翻译 | 示例
           

摘要

Buzhong Yiqi decoction (BYD) is a well-known ancient tonic prescription in traditional Chinese medicine (TCM). The purpose of this study is to identify active components of BYD involved in promoting proliferation of mesenchymal stem cells (MSCs) and to investigate its mechanism. BYD was extracted with petroleum ether, ethanol, and water. Evidence provided by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, bromodeoxyuridine, proliferation cell nuclear antigen immunoreactivity, cell cycle analysis, and gas chromatography-mass spectrometry indicated that hexadecanoic acid (HA) in BYD extracted with petroleum ether is the active compound responsible for increasing proliferation of MSCs. Western blot analysis show that HA significantly increase retinoic acid receptor (RAR) levels of MSCs, but not estrogen receptor, thyroid hormone receptor, vitamin D receptor, glucocorticoid receptor, and peroxisome proliferator-activated receptor. Reverse transcription-polymerase chain reaction revealed that HA significantly increased RAR mRNA levels. Furthermore, the mechanism of HA action depends on RAR pathway and up-regulates expression of mRNA for insulin-like growth factor-I, the target gene of RAR. Our findings have now allowed for a refinement in our understanding of TCM with respect to pharmacological regulation of stem cells and may be useful to stem cell biology and therapy.
机译:补中益气汤(BYD)是一种著名的中药古代补虚方。这项研究的目的是确定参与促进间充质干细胞(MSCs)增殖的BYD活性成分,并研究其机制。用石油醚,乙醇和水提取比亚迪。 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物,溴脱氧尿苷,增殖细胞核抗原免疫反应性,细胞周期分析和气相色谱-质谱法提供的证据表明,十六烷酸(HA)用石油醚提取的比亚迪是负责增加MSC增殖的活性化合物。蛋白质印迹分析表明,HA可显着增加MSC的维甲酸受体(RAR)水平,但不会增加雌激素受体,甲状腺激素受体,维生素D受体,糖皮质激素受体和过氧化物酶体增殖物激活的受体。逆转录-聚合酶链反应显示HA显着增加RAR mRNA水平。此外,HA作用的机制取决于RAR途径,并上调胰岛素样生长因子-I(RAR的靶基因)的mRNA表达。我们的发现现在使我们对中药对干细胞的药理学调节有了更进一步的了解,可能对干细胞生物学和治疗有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号